Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Domiphen bromide+lidocaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrocarbonat 2,2 % injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocain 2 % injektionsvæske, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocain 2 % injektionsvæske, 20 ml hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lignocain 5 % + hydrocortisonacetat 0,275 % salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocain 2 %/adrenalin 1 til 200.000 injektionsvæske, 20 ml hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocain 2 % injektionsvæske, 5 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocain 1 % injektionsvæske, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocain 1 %/adrenalin 1 til 200.000 injektionsvæske, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocain 1 % injektionsvæske, 5 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,5 % injektionsvæske, opløsning, 10 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,5 % injektionsvæske, opløsning, 20 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,5 % injektionsvæske, opløsning, 20 ml hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 % injektionsvæske, opløsning, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 % injektionsvæske, opløsning, 5 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 % injektionsvæske, opløsning, 10 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 % injektionsvæske, opløsning, 20 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % injektionsvæske, opløsning, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % injektionsvæske, opløsning, 5 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % injektionsvæske, opløsning, 20 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % injektionsvæske, opløsning, 20 ml hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid, neutral 1 % injektionsvæske, i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
dexamethasonnatriumphosphat + lidocainhydrochlorid 4 mg/10 mg/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,2 % + lidocainhydrochlorid 0,05 % halsspray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing bupivacaine and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
lidocain 1 %/bupivacain 0,375 % injektionsvæske, opløsning, 10 ml hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocain 2,5 %/prilocain 2,5 % periodontalgel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 10 %/adrenalin 0,1 % iontoforetisk plaster til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing lidocaine and neomycin and polymyxin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
3 |
lidocainhydrochlorid 2 % viskøs opløsning til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 20 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Domiphen bromide 500 microgram and lidocaine hydrochloride 5 mg oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Intentional lignocaine poisoning (disorder) |
Causative agent |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 2 mg/g and lidocaine hydrochloride 10 mg/g cutaneous spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing hydrocortisone and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing lidocaine and tetracaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
lidocain 70 mg + tetracain 70 mg depotplaster |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing cetylpyridinium and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing lidocaine and zinc oxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing allantoin and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing domiphen and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing clove oil and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing cetalkonium and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing aminoacridine and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocain 2,5 % salve til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lidocaine hydrochloride |
Is a |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing hyaluronic acid and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing lidocaine in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing lidocaine in oropharyngeal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Accidental poisoning caused by lignocaine (disorder) |
Causative agent |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
lidocain 0,5 mg, pulver til injektionsvæske til intrakutan anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Allergy to lidocaine (finding) |
Causative agent |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline- and lidocaine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine hydrocarbonate (substance) |
Is a |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lidocaine hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lidocaine hydrocarbonate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 1% conventional release solution for injection ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Domiphen- and lidocaine-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely lidocaine 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine 10 mg/actuation oromucosal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine 10 mg/actuation oromucosal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing lidocaine and prilocaine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing lidocaine and tetracaine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing lidocaine and methylprednisolone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine-containing product in gingival dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing lidocaine and phenylephrine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Cetylpyridinium- and lidocaine-containing product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Hydrocortisone- and lidocaine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only allantoin and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Cetylpyridinium and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Bupivacaine and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Aminoacridine and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only chlorhexidine and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only cetalkonium and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Clove oil and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Adrenaline and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Domiphen and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only hydrocortisone and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Fluorescein stain and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only lidocaine and methylprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine and neomycin and polymyxin B only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
3 |
Product containing only lidocaine and oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine and phenylephrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine and tetracaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine and prilocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only lidocaine and zinc oxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only hyaluronic acid and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |